Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community-acquired pneumonia

Br J Clin Pharmacol. 2014 Jul;78(1):78-83. doi: 10.1111/bcp.12295.

Abstract

Aim: The use of corticosteroids as adjunctive therapy might be effective in patients with community-acquired pneumonia (CAP). Oral administration of dexamethasone is a practical and safer alternative to the intravenous route. Since patients hospitalized with pneumonia might have delayed gastric emptying, this study explored systemic exposure in terms of area under the concentration-time curve (AUC) of oral dexamethasone in patients hospitalized with CAP.

Methods: In this randomized, open label study, 30 patients admitted with CAP were randomized to receive either 4 mg intravenous or 6 mg oral dexamethasone for 4 consecutive days. Serial blood samples were obtained before and after drug administration.

Results: Median AUC to infinity was 626 μg l(-1) h (IQR 401-1161) for the intravenous group and 774 μg l(-1) h (IQR 618-1146) for the oral group. The AUC ratio of 6 mg oral and 4 mg intravenous dexamethasone was 1.22 (95% confidence interval (CI) 0.81, 1.82), which represents a bioavailability of 81% (95% CI 54, 121) after correction for differences in dexamethasone dose.

Conclusions: Bioavailability of oral dexamethasone in patients hospitalized with pneumonia is sufficient. This makes oral dexamethasone an appropriate alternative for intravenous administration in these patients.

Keywords: CAP; bioavailability; community-acquired pneumonia; dexamethasone; intravenous; oral.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Aged
  • Biological Availability
  • Community-Acquired Infections / blood*
  • Community-Acquired Infections / drug therapy*
  • Dexamethasone / administration & dosage*
  • Dexamethasone / pharmacokinetics*
  • Female
  • Glucocorticoids / administration & dosage*
  • Glucocorticoids / pharmacokinetics*
  • Hospitalization
  • Humans
  • Injections, Intravenous
  • Male
  • Pneumonia / blood*
  • Pneumonia / drug therapy*

Substances

  • Glucocorticoids
  • Dexamethasone